Evidence map›Paper›PMID 29440928›Full record

ArticleCancer management and research2018

Early diagnostic potential of

Bujiang Wang, Haojun Song, Haizhong Jiang, Yangbo Fu, Xiaoyun Ding, Chongchang Zhou

Open access · goldAbstract read
In one paragraph

Article in Cancer management and research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Biomarker Use in Barrett's Esophagus Surveillance.The American journal of gastroenterology · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2021
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bujiang WangDepartment of Gastroenterology, Laboratory of Digestive Diseases, Ningbo First Hospital, Ningbo.
Haojun SongDepartment of Gastroenterology, Laboratory of Digestive Diseases, Ningbo First Hospital, Ningbo.
Haizhong JiangDepartment of Gastroenterology, Laboratory of Digestive Diseases, Ningbo First Hospital, Ningbo.
Yangbo FuDepartment of Gastroenterology, Laboratory of Digestive Diseases, Ningbo First Hospital, Ningbo.
Xiaoyun DingDepartment of Gastroenterology, Laboratory of Digestive Diseases, Ningbo First Hospital, Ningbo.
Chongchang ZhouDepartment of Otorhinolaryngology Head and Neck Surgery, Lihuili Hospital of Ningbo University, Ningbo, Zhejiang, People's Republic of China.
Ningbo First Hospital · CNNingbo University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe hypermethylation of APC gene is observed in various cancers, including esophageal cancer (EC). However, the association between APC methylation and the initiation and progression of EC is poorly understood. PURPOSE AND

methodsThe current study systematically reviewed studies on abnormal methylation of APC in EC and quantitatively synthesized 18 studies by meta-analysis involving 1008 ECs, 570 Barrett's esophagus (BE), and 782 controls.

resultsOur results showed higher methylation of APC in EC (OR = 23.33,

conclusionOur results imply that APC methylation detection is a potential diagnostic biomarker for EC and BE.

Indexed as

APCBarrett’s esophagusesophageal cancermethylation

Identifiers

PMID29440928
PMCPMC5798573
OpenAlexW2790942644

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.